Achromobacter spp. are emerging respiratory pathogens in cystic fibrosis patients. Since 2013 the genus Achromobacter includes 15 species for which innate antibiotic resistance is unknown.
Achromobacter spp. are nonfermenting Gram-negative bacilli considered as emerging pathogens in cystic fibrosis (CF) patients [1, 2] . Since the description of the type species, A. xylosoxidans [3] , 14 other species have been ranked into the genus Achromobacter: A. piechaudii and A. ruhlandii [4] , A. denitrificans [5] , A. spanius and A. insolitus [6] , A. marplatensis [7] , A. animicus, A. mucicolens, A. pulmonis and A. spiritinus [8] , A. insuavis, A. aegrifaciens, A. anxifer and A. dolens [9] , and 6 other genogroups. These 21 species and genogroups can be distinguished by the multilocus sequence typing (MLST) scheme proposed by Spilker et al. [10] . The study demonstrated that sequencing a 765 bp internal fragment of the only nrdA gene is sufficient for correct identification [11] . Because of the actual difficulty in performing accurate species identification, most isolates are still referred by default as A. xylosoxidans, preventing the evaluation of the real epidemiology and clinical impact of each species. Moreover, the data about the mechanisms of innate antibiotic resistance are scarce [12, 13] . The AxyXYOprZ RND efflux system confers resistance to aminoglycosides (AG) in A. xylosoxidans AXX-A since reclassified as A. insuavis (accession number AFRQ01000000). Nevertheless, AG, which take an important part in CF antimicrobial therapy, remain active against some isolates of Achromobacter spp. [14, 15] .
We sought to describe the distribution of AG-resistant isolates among the different species of the genus Achromobacter and to search for the axyXY-oprZ efflux operon in AG-resistant and -susceptible isolates to assess if AG resistance is correlated with the presence of the operon.
Forty-nine Achromobacter isolates harbouring various AG resistance patterns were included in this study: 21 from CF patients' sputum, 20 from non-CF clinical samples and eight from environmental samples ( Table 1) . Most of them (n = 35) were collected in our laboratory; nine collection strains were purchased from the Institut Pasteur, France, including six type strains, and five were kindly provided by J. J. LiPuma (Department of Pediatrics and Communicable Diseases, University of Michigan Medical School). Isolates were identified at the genus level either by using the conventional biochemical method API 20NE (bioMérieux) or by sequencing the 16S rRNA gene. The identification to the species level was performed by sequencing the 765 bp internal nrdA fragment followed by Achromobacter PubMLST database query (http://pubmlst.org/achromobacter/). Minimal inhibitory concentrations (MICs) of tobramycin, amikacin, gentamicin and netilmicin were measured by the Etest method (bioMérieux). Mueller-Hinton agar plates were inoculated by swabbing from a 0.5 McFarland turbidity bacterial suspension, and MICs were recorded after overnight incubation at 37°C by two persons independently. The phenotype "AGsusceptible" (AG-S) was attributed to isolates susceptible to all AG and the phenotype "AG-resistant" (AG-R) to the other by using the European Committee on Antimicrobial Susceptibility Testing clinical breakpoints for Pseudomonas spp. (http://www. eucast.org/clinical_breakpoints/; version 5.0). Detection of the axyXY-oprZ operon was performed by 2 PCRs targeting the genes (a) axyY, encoding the RND transporter, and (b) oprZ, encoding the outer membrane factor. PCRs were carried out in reaction mixtures containing dNTP (0.2 mM), forward and reverse primers (0.25 μM each), Taq polymerase (Fermentas) (2.5 U) with the supplied buffer, MgCl 2 (1.5 mM), dimethyl sulfoxide (5% volume) and template DNA (1 μL), adjusted with water to a final volume of 50 μL. The cycling parameters were 94°C for 10 minutes, 30 cycles of 94°C for 90 seconds, annealing primers temperature for 90 sections, 72°C for 60 seconds, and 72°C for 10 minutes. The results are summarized in Table 1 .
The nrdA sequences analysis allowed identification of 48 of the 49 isolates. nrdA sequence of ACH-CF-583 harboured 39 nucleotide differences, with its closest match in database (genogroup 19) (Fig. 1) indicating that this isolate belonged to a novel genogroup or a novel species. Fourteen of the 49 studied isolates were categorized as AG-S. Interestingly, all isolates belonging to a same species harboured the same AG resistance pattern. In the resistant species, the level of resistance was sometimes variable among the isolates. Nevertheless, none of these isolates had been categorized as susceptible for all four AG molecules. A variable expression level of the efflux operon might account for these differences as already observed for Pseudomonas aeruginosa [16] . Distribution of the AG-S and AG-R isolates according to species identification is represented in a dendrogram (Fig. 2 ) generated from the nrdA sequences using the neighbour-joining method with 1000 bootstrap replications (MEGA6). We also included in the dendrogram the nrdA sequences of the type strains (LMG) of the recently described novel species. AG-S isolates were divided up into two clusters of species including A. animicus and A. mucicolens (cluster 1), and A. spanius and A. piechaudii (cluster 2). These two clusters were supported by high bootstrap values. All other isolates were AG-R and did not belong to cluster 1 or 2. They included the 16 A. xylosoxidans isolates and all isolates from the species A. aegrifaciens, A. denitrificans, A. dolens, A. genogroup 12, A. insolitus, A. insuavis, A. marplatensis and A. ruhlandii. A similar tree topology was obtained by using the maximum likelihood and the maximum parsimony methods (data not shown). There was a perfect correlation between the AG resistance profile and the presence of the AxyXY-OprZ efflux system. Indeed, the operon was detected in all AG-R isolates and not in the AG-S ones. An additional PCR was performed in all AG-S isolates with primers designed in flanking sequences of the axyXY-oprZ operon and confirmed the absence of the whole operon. Because the GC content of the efflux operon is similar to that of whole genome, we hypothesized that a deletion occurred in the course of evolution.
These findings indicate that susceptibility or resistance to AG might be a phenotypic trait correlated with Achromobacter species evolution.
To date, and to our knowledge, only four studies including an appropriate Achromobacter identification method report distribution of the different Achromobacter species in clinical samples. They indicate that A. xylosoxidans is the species the most frequently recovered from CF patients [11, [17] [18] [19] . Other species are also widely prevalent: A. ruhlandii, A. dolens and A. insuavis. It is noteworthy that all isolates belonging to these four species have been categorized as AG-R in the present work. One can therefore wonder whether these AG-R species are more pathogenic than the AG-S ones, which might explain their high prevalence. One might also hypothesize that these species have emerged under the selection pressure of AG treatment frequently prescribed to those in the CF population.
In conclusion, AG resistance is the first phenotypic characteristic correlated with the different species of the genus Achromobacter. More studies including accurate species level identification are required in order to improve knowledge about the epidemiology and virulence of these pathogens. They might also help to elucidate whether the use of inhaled AG promotes selection of Achromobacter that belong to the species harbouring the AxyXY-OprZ efflux system. 
